Figure 1
Figure 1. Mutations discovered by massive parallel sequencing of 102 MCL cases. (A) Total numbers of nonsynonymous mutations confirmed in 13 target genes analyzed. Next to the well-known and previously described mutations in ATM, TP53, and NOTCH1, UBR5 has the highest percentage of deleterious mutations including 7 splice-site affecting mutations. (B) The schematic represents the status of the 5 most recurrently mutated genes (rows) in MCL in 102 patients (columns) analyzed (red: splice site mutation; dark blue: indel; light blue: nonsense mutation; gray: missense mutation; and white: wild type. Asterisks highlight mutations validated as being somatic by Sanger sequencing.

Mutations discovered by massive parallel sequencing of 102 MCL cases. (A) Total numbers of nonsynonymous mutations confirmed in 13 target genes analyzed. Next to the well-known and previously described mutations in ATM, TP53, and NOTCH1, UBR5 has the highest percentage of deleterious mutations including 7 splice-site affecting mutations. (B) The schematic represents the status of the 5 most recurrently mutated genes (rows) in MCL in 102 patients (columns) analyzed (red: splice site mutation; dark blue: indel; light blue: nonsense mutation; gray: missense mutation; and white: wild type. Asterisks highlight mutations validated as being somatic by Sanger sequencing.

Close Modal

or Create an Account

Close Modal
Close Modal